Skip to contentR
Rhythm Pharmaceuticals, Inc.
R
RYTMRhythm Pharmaceuticals, Inc. Released May 14, 2018, after the close
10-Q filed May 14, 2018, 44 days after period end · 0001558370-18-004752
Q1 2018 · 10-Q
Revenue—
Net Income-$16.46M-$16.46MN/M vs Q1 2017N/M vs Q4 2017 EPS Diluted
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
-$0.60-$0.60N/M vs Q1 2017N/M vs Q4 2017 Operating Income-$17,001,000N/M Operating Cash Flow-$11,651,000N/M ended Mar 31, 2018 · filed May 14, 2018 · 44 d after period end